CD98 immunoreactivity in multinucleated giant cells of glioblastomas: An immunohistochemical double labeling study

Neuropathology

Volumn 28, Issue 2, 2008, Pages 127-131

  Takeuchi, Hiroaki ^a   Kubota, Toshihiko ^a   Kitai, Ryuhei ^a   Nakagawa, Takao ^a   Hashimoto, Norichika ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

CD98; Glioblastoma; Immunohistochemistry; Ki67; Multinucleated giant cell

Indexed keywords

CD98 ANTIGEN; FUSION REGULATORY PROTEIN 1; KI 67 ANTIGEN; PARAFFIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GIANT CELL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD98; BRAIN NEOPLASMS; CELL FUSION; FEMALE; GIANT CELLS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED;

EID: 41149165283     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00859.x     Document Type: Article

References (21)

1. Ibayashi N, Herman MM, Boyd JC et al. Kinetics and glial fibrillary acidic (GFA) protein production in a transplantable human giant cell glioblastoma (D-212 MG) of near haploid karyotype maintained in an organ culture system. An immunohistochemistry study. Neuropathol Appl Neurobiol 1990 16 : 27 37.
2. Katoh M, Aida T, Sugimoto S et al. Immunohistochemical analysis of giant cell glioblastoma. Pathol Int 1995 45 : 275 282.
3. Kawano H, Kubota T, Sato K, Goya T, Arikawa S, Wakisaka S. Immunohistochemical study of giant cell in glioblastoma. Clin Neuropathol 1995 14 : 118 123.
4. Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and P53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med 2003 127 : 1187 1191.
5. Fujita M, Mizuno M, Nagasaka T et al. Aurora-B dysfunction of multinucleated giant cells in glioma detected by site-specific phosphorylated antibodies. J Neurosurg 2004 101 : 1012 1017.
6. Maeda K, Mizuno M, Wakabayashi T et al. Morphological assessment of the development of multinucleated giant cells in glioma by using mitosis-specific phosphorylated antibodies. J Neurosurg 2003 98 : 854 859.
7. Takeuchi H, Sato K, Ido K, Kubota T. Mitotic activity of multinucleated giant cells with glial fibrillary acidic protein immunoreactivity in glioblastomas: an immunohistochemical double labeling study. J Neurooncol 2006 78 : 15 18.
8. Namba K, Nishio M, Mori K et al. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. Cell Immunol 2001 213 : 104 113.
9. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993 197 : 143 158.
10. Ohgimoto S, Tabata N, Suga S et al. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J Immunol 1995 155 : 3585 3592.
11. Okamoto K, Ohgimoto S, Nishio M et al. Paramyxovirus-induced syncytium cell formation is suppressed by a dominant negative fusion regulatory protein-1 (FRP-1)/CD98 mutated construct: an important role of FRP-1 in virus-induced cell fusion. J Gen Virol 1997 78 : 775 783.
12. Tajima M, Higuchi S, Higuchi Y et al. Suppression of FRP-1/CD98-mediated multinucleated giant cell and osteoclast formation by an anti-FRP-1/CD98 mAb, HBJ 127, that inhibits c-src expression. Cell Immunol 1999 193 : 162 169.
13. Haynes BF, Hemler ME, Mann DL et al. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 1981 126 : 1409 1414.
14. Hemler ME, Strominger JL. Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines. J Immunol 1982 129 : 623 628.
15. Quackenbush E, Clabby M, Gottesdiener KM et al. Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth. Proc Natl Acad Sci USA 1987 84 : 6526 6530.
16. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998 273 : 23629 23632.
17. Yanagida O, Kanai Y, Chairoungdua A et al. Human 1-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001 1514 : 291 302.
18. Boado RJ, Yi J, Nagaya LM, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 1999 96 : 12079 12084.
19. Kudo Y, Boyd CA, Millo J, Sargent IL, Redman CW. Manipulation of CD98 expression affects both trophoblast cell fusion and amino acid transport activity during syncytialization of human placental BeWo cells. J Physiol 2003 550 : 3 9.
20. Gicklhorn D, Eickmann M, Meyer G, Ohlin M, Radsak K. Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion. J Gen Virol 2003 84 : 1859 1862.
21. Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol 1999 73 : 9568 9575.